stars 1 stars 2 stars 3

Vaxconsulting has developed a unique bioinformatic platform to identify new anti-cytokine drug candidates : - small-molecule inhibitors, - immunotherapy using immunogenic peptides (vaccines, monoclonal antibodies). The bioinformatics platform plays a central role in the molecular modelling of the interaction of drug candidates with the targeted cytokines, leading to an efficient and cost-effective drug development process, which is the core of Vaxconsulting’s expertise.

Vaxconsulting Questions

The Vaxconsulting annual revenue was $5.9 million in 2026.

Vaxconsulting is based in Paris, Ile-de-France.

The NAICS codes for Vaxconsulting are [54, 541, 5417, 54171, 541713].

The SIC codes for Vaxconsulting are [87, 873].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users